Sachin Lawande - Feb 28, 2025 Form 4 Insider Report for VISTEON CORP (VC)

Role
CEO and President, Director
Signature
Heidi A. Sepanik, Corporate Secretary, Visteon Corporation on behalf of Sachin S. Lawande
Stock symbol
VC
Transactions as of
Feb 28, 2025
Transactions value $
$0
Form type
4
Date filed
3/4/2025, 04:22 PM
Previous filing
Feb 24, 2025
Next filing
Mar 12, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VC Common Stock 288K Feb 28, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VC Performance Rights Award $0 +69.2K $0.00 69.2K Mar 1, 2025 Common Stock 69.2K Direct F1
transaction VC Restricted Stock Units Award $0 +46.1K $0.00 46.1K Mar 1, 2025 Common Stock 46.1K Direct F2
transaction VC Employee Stock Option (right to buy) Expiration of short derivative position $0 -47K -100% $0.00 0 Feb 28, 2025 Common Stock 47K $124.34 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each performance right represents a contingent right to receive one share of Visteon common stock. The vesting of the performance right is based on relative shareholder return and return on invested capital metrics over a three year performance period and payable in stock, subject to tax withholding.
F2 Restricted Stock Units vest to the extent of 33% of the units granted on the following March 15th of each year after the date of grant. Each Restricted Stock Unit will be converted and distributed to me, without payment, in stock upon vesting and based upon the then current market value of a share of Visteon common stock, subject to tax withholding.
F3 Mr. Lawande received no value in connection with the expiration of the option granted to him in 2018.
F4 The option is exercisable to the extent of one third of the shares optioned after one year from the date of grant, two-thirds in two years and in full after three years.